Status:
COMPLETED
Post-radiation Prostate Cancer Local Recurrences: Detection With Histoscanning™ and MRI
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Prostate Cancer Recurrent
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Inclusion criteria: * Patients with biochemical recurrence (Phoenix criteria: PSA nadir + 2 ng/ml) after radiation therapy for prostate cancer addressed for prostate biopsy OR * Patients referred to ...
Eligibility Criteria
Inclusion
- Patients with biochemical recurrence (Phoenix criteria: PSA nadir + 2 ng/ml) after radiation therapy for prostate cancer addressed for prostate biopsy OR Patients referred to our institution for biopsy-proven local recurrence after radiation therapy for prostate cancer but needing a re-assessment with biopsy (insufficient number of biopsy and/or imprecise location of positive biopsy and/or questionable diagnostic of recurrence)
- IRB-approved informed consent signed
Exclusion
- Contraindication to MRI
- Contraindication to endorectal examination
- Contraindication to prostate biopsy
- History of allergy to gadolinium chelates
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01857037
Start Date
May 1 2011
End Date
August 1 2014
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prof O. ROUVIERE
Lyon, Rhône, France, 69437